title: Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study.
abstract: GH increases circulating insulin-like growth factor I (IGF-I), which can promote the growth and differentiated function of ovarian granulosa and theca cells. Reported studies of GH as an adjunct to menotropin stimulation in women, largely those with ovarian dysfunction, have not consistently shown a benefit of GH, despite increases in serum and follicular fluid IGF-I. We hypothesized that changes in intrafollicular IGF-binding proteins (IGFBPs), which can antagonize IGF actions on granulosa cells, may underlie the inconsistent effects of GH. In the present study of GH, administered in double-blind, placebo-controlled, cross-over fashion to regularly cycling women undergoing in vitro fertilization, we found that follicular fluid levels of IGFBP-1, -3, and -4 and serum levels of IGFBP-3, as well as follicular fluid and serum IGF-I, were significantly increased in the GH-treated cycles, when compared with the placebo cycle of the same patient. We suggest that the net increase in intrafollicular IGFBPs in GH cycles may mitigate the potential beneficial effect of increased IGF-I.
authors.affiliation: Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco 94143-0132, USA.
authors.forename: J
authors.initials: J
authors.lastname: Rabinovici
authors.forename: N A
authors.initials: NA
authors.lastname: Cataldo
authors.forename: P
authors.initials: P
authors.lastname: Dandekar
authors.forename: S M
authors.initials: SM
authors.lastname: Rosenthal
authors.forename: S E
authors.initials: SE
authors.lastname: Gargosky
authors.forename: N
authors.initials: N
authors.lastname: Gesundheit
authors.forename: M C
authors.initials: MC
authors.lastname: Martin
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D015571:Follicular Fluid / Q000378:metabolism*; D019382:Human Growth Hormone / Q000494:pharmacology*; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008024:Ligands; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism*; D010919:Placebos; D011863:Radioimmunoassay; D013268:Stimulation, Chemical
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D018969:Insulin-Like Growth Factor Binding Proteins; D008024:Ligands; D010919:Placebos; D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I